Elsevier developing risk calculator for DDIs ‘aligned with pharma’s needs and challenges’ 24-Sep-2019 By Melissa Fassbender To improve patient safety and reduce risk, Elsevier is developing an improved drug-drug interaction risk calculator in collaboration with several pharma partners, including Boehringer Ingelheim, Eli Lilly, and Servier.